Trademark: 88073859
Word
AB CHECK
Status
Registered
Status Code
700
Status Date
Tuesday, August 8, 2023
Serial Number
88073859
Registration Number
7133412
Registration Date
Tuesday, August 8, 2023
Mark Type
3000
Filing Date
Friday, August 10, 2018
Published for Opposition
Tuesday, September 29, 2020

Trademark Owner History
AbCheck s.r.o. - Original Registrant

Classifications
42 Scientific and technological services and research projects for the preparation of peptide and antibody libraries, namely, chemical analysis; scientific and technological services and research projects for the identification and characterisation of binding molecules, namely, in the field of antibody discovery, antibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, medical research in the field of antibody discovery, antibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, in the field of antibody discovery, antibody research and antibody optimization, namely, scientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discovery, namely, medical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, medical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technology, namely, scientific research in the field of antibody research and antibody optimization
The mark consists of letters "AB" and "CHECK" separated by an array of circles.
Color is not claimed as a feature of the mark.
"AB" OR "CHECK"

Trademark Events
Aug 8, 2023
Notice Of Registration Confirmation Emailed
Aug 8, 2023
Registered-Principal Register
Jul 6, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 5, 2023
Allowed Principal Register - Sou Accepted
Jun 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2023
Statement Of Use Processing Complete
Jun 8, 2023
Sou Extension 5 Granted
May 24, 2023
Sou Extension 5 Filed
May 24, 2023
Use Amendment Filed
May 30, 2023
Case Assigned To Intent To Use Paralegal
May 24, 2023
Teas Extension Received
May 24, 2023
Teas Statement Of Use Received
Nov 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2022
Sou Extension 4 Granted
Oct 28, 2022
Sou Extension 4 Filed
Oct 28, 2022
Teas Extension Received
May 19, 2022
Notice Of Approval Of Extension Request E-Mailed
May 17, 2022
Sou Extension 3 Granted
May 17, 2022
Sou Extension 3 Filed
May 17, 2022
Teas Extension Received
Oct 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2021
Sou Extension 2 Granted
Oct 26, 2021
Sou Extension 2 Filed
Oct 26, 2021
Teas Extension Received
Apr 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2021
Sou Extension 1 Granted
Apr 20, 2021
Sou Extension 1 Filed
Apr 20, 2021
Teas Extension Received
Nov 24, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 29, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 29, 2020
Published For Opposition
Sep 9, 2020
Notification Of Notice Of Publication E-Mailed
Aug 26, 2020
Approved For Pub - Principal Register
Jun 25, 2020
Teas/Email Correspondence Entered
Jun 25, 2020
Correspondence Received In Law Office
Jun 25, 2020
Teas Request For Reconsideration Received
Apr 19, 2020
Notification Of Final Refusal Emailed
Apr 19, 2020
Final Refusal E-Mailed
Apr 19, 2020
Final Refusal Written
Jan 16, 2020
Teas/Email Correspondence Entered
Jan 15, 2020
Correspondence Received In Law Office
Jan 15, 2020
Teas Response To Office Action Received
Jul 17, 2019
Notification Of Non-Final Action E-Mailed
Jul 17, 2019
Non-Final Action E-Mailed
Jul 17, 2019
Non-Final Action Written
Jun 13, 2019
Teas/Email Correspondence Entered
Jun 13, 2019
Correspondence Received In Law Office
Jun 13, 2019
Teas Response To Office Action Received
Jan 2, 2019
Notification Of Non-Final Action E-Mailed
Jan 2, 2019
Non-Final Action E-Mailed
Jan 2, 2019
Non-Final Action Written
Nov 28, 2018
Assigned To Examiner
Aug 21, 2018
Notice Of Design Search Code E-Mailed
Aug 18, 2018
New Application Office Supplied Data Entered
Aug 14, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24